Hanmi Science to strengthen medical device business < Device/ICT < 기사본문 - KBR - KBR

Hanmi Science, which precocious merged with affiliate Hanmi Healthcare, said it volition fortify its aesculapian instrumentality business, including surgical materials.

Hanmi Science announced its volition to fortify its aesculapian instrumentality business.

Hanmi Science, a holding institution of Hanmi Group, decided to merge with its affiliates, Hanmi Healthcare, successful September and completed the merger process done a solution of the committee of directors successful November.

Lim Jong-hoon, who antecedently served arsenic the CEO of Hanmi Healthcare, volition oversee the healthcare concern arsenic CEO of Hanmi Science.

Hanmi Science announced that it plans to reorganize the aesculapian instrumentality unit, which is the main concern of Hanmi Healthcare, and turn the size of the unit. Hanmi Science plans to boost the aesculapian instrumentality business’ 30 cardinal won ($22.6 million) income to much than 50 cardinal won.

Hanmi Healthcare supplies surgical attraction materials specified arsenic Guardix, an anti-adhesion cause that prevents organs oregon nerves from sticking unneurotic during surgery, Surgiguard Gauze, a surgical hemostatic agent, and Liquiband, utilized for sutures aft surgery.

According to Hanmi Science, the aesculapian instrumentality concern assemblage accounts for 30 percent of Hanmi Healthcare's full sales, and income of large products person grown by astir 31 percent implicit the past 3 years.

Notably, successful the lawsuit of Guardix, it occupies 40 percent marketplace stock successful the home payroll anti-adhesion cause marketplace and is signaling yearly income of 20 cardinal won. Hanmi Science has besides precocious launched Hyvixel, an anti-adhesion cause for spinal surgery.

In addition, the institution has entered into partnerships with astir 10 Korean and overseas companies implicit the past 4 years, and introduced assorted products specified arsenic inflammatory marker trial reagents, surgical adhesives, and hemostatic agents.

Hanmi Science besides markets aesculapian devices for animals and is launching and selling carnal diagnostic reagents and hemostatic gauze.

Hanmi Science plans to continuously observe products that tin summation synergy with the different companies wrong the Hanmi group.

"The aesculapian instrumentality portion is an important concern of the company's aboriginal and volition service arsenic the company's halfway currency cow," a Hanmi Science authoritative said. "In summation to the company's achievements successful the tract of surgical attraction materials, Hanmi Healthcare volition grow its concern to encompass the full aesculapian instrumentality industry."